{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:03:11Z","timestamp":1790402591852,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>We aimed to evaluate the effects of integrated Chinese and Western medical therapeutic modalities on clinical prognosis in a population with stable angina pectoris (SAP) of coronary heart disease (CHD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a prospective cohort study, 732 patients with SAP of CHD hospitalized in the Integrated Cardiology Unit of the China-Japan Friendship Hospital From October 2020 to October 2021 were included. The patients were divided into integrated treatment and conventional treatment groups according to whether they had been taking Chinese medicine for more than 6 months per year. The occurrence of composite cardiovascular events (CVEs), including cardiac death, non-fatal myocardial infarction, revascularization, stroke, all-cause death, and readmission due to angina attack, heart failure, or malignant arrhythmia, was recorded during follow-up. The effects of different treatment modalities on prognosis were evaluated using univariate and multifactorial logistic regression. Logistic regression models were evaluated using receiver operating characteristic (ROC) curves. In sensitivity analysis, the correlation between treatment modality and outcome events was corrected by rematching the two groups of patients using the propensity score matching (PSM) method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The data from 690 patients were included in the analysis, with 327 patients in the integrated treatment group and 363 patients in the conventional treatment group. CVEs occurred in 19 patients (5.8%) in the integrated treatment group and 37 patients (10.2%) in the conventional treatment group. The proportion of outcome events was significantly lower in the combination treatment group than in the conventional treatment group (<jats:italic>P<\/jats:italic>\u2009=\u20090.037). Covariate correction by multimodal multifactorial logistic regression revealed a lower risk of CVEs in patients receiving integrated therapy compared with conventional therapy (OR\u2009=\u20090.246, 95% CI\u2009=\u20090.097\u20130.622, <jats:italic>P<\/jats:italic>\u2009=\u20090.003). Moreover, a history of renal insufficiency (OR\u2009=\u20093.991, 95% CI\u2009=\u20091.164\u201313.684, <jats:italic>P<\/jats:italic>\u2009=\u20090.028) and a higher Gensini score (OR\u2009=\u20091.039, 95% CI\u2009=\u20091.028\u20131.050, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001) were risk factors for the development of CVEs. Model evaluation showed that C-statistic\u2009=\u20090.955 and area under the ROC curve (AUC)\u2009=\u20090.955. After PSM correction, the results still showed that integrated Chinese and Western medical treatment reduced the occurrence of CVEs in patients compared with Western treatment alone (OR\u2009=\u20090.339, 95% CI\u2009=\u20090.131\u20130.874, <jats:italic>P<\/jats:italic>\u2009=\u20090.025).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Integrated treatment based on Chinese and Western medicine might improve the prognosis and reduce the risk of CVEs in this disease population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>China Clinical Trials Registry, ChiCTR1800017891, Registered 20 August 2018, <jats:ext-link>http:\/\/www.chictr.org.cn\/showproj.aspx?proj\u2009=\u200930170<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1194082","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:20:21Z","timestamp":1684477221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrated Chinese and Western medicine for stable angina pectoris of coronary heart disease: a real-world study including 690 patients"],"prefix":"10.3389","volume":"10","author":[{"given":"Linghua","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100655","DOI":"10.1016\/j.cpcardiol.2020.100655","article-title":"Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging","volume":"46","author":"Katta","year":"2014","journal-title":"Curr Probl Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease","volume":"34","author":"Montalescot","year":"2014","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ejhf.130","article-title":"Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events","volume":"16","author":"Mentz","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2021.1527","article-title":"Diagnosis and management of stable angina: a review","volume":"325","author":"Joshi P","year":"2021","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"Br Med J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/01.cir.59.3.607","article-title":"Report of the joint international society and federation of cardiology\/world health organization task force on standardization of clinical nomenclature","volume":"59","year":"1979","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines, and the American college of physicians, American association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamacardio.2020.7478","article-title":"Interpretation of the Seattle angina questionnaire as an outcome measure in clinical trials and clinical care: a review","volume":"6","author":"Thomas","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2019.05.012","article-title":"A guide for gensini score calculation","volume":"287","author":"Rampidis","year":"2019","journal-title":"Atherosclerosis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1177\/0962280218784726","article-title":"Sample size for binary logistic prediction models: beyond events per variable criteria","volume":"28","author":"van Smeden","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.19852\/j.cnki.jtcm.2021.01.017","article-title":"Traditional Chinese medicine in the prevention and treatment of stable angina pectoris in patients with coronary heart disease based on the theory of \u201cphlegm and blood stasis\u201d under guidance of evidence-based medicine: a prospective cohort study","volume":"41","author":"Chen","year":"2021","journal-title":"J Tradit Chin Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/acm.2020.0361","article-title":"Effect of yugengtongyu granules in patients with stable coronary artery disease on reducing adverse cardiovascular events: a double-blind controlled trial","volume":"27","author":"Wang","year":"2021","journal-title":"J Altern Complement Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"918689","DOI":"10.3389\/fphar.2022.918689","article-title":"The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: a systematic review and network meta-analysis of 179 trials","volume":"13","author":"Huang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1002713","DOI":"10.3389\/fphar.2022.1002713","article-title":"Efficacy and safety of shexiang baoxin pill for stable coronary artery disease: a systematic review and meta-analysis of 42 randomized controlled trials","volume":"13","author":"Wei","year":"2022","journal-title":"Front Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e12097","DOI":"10.1097\/MD.0000000000012097","article-title":"Study on syndrome differentiation and treatment in the management of chronic stable coronary artery disease to improve quality of life","volume":"97","author":"Bi","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1573403X14666180222102312","article-title":"Management of measurable Variable cardiovascular disease\u2019 risk factors","volume":"14","author":"Francula-Zaninovic","year":"2018","journal-title":"Curr Cardiol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5551\/jat.ED064","article-title":"Risk factor of cardiovascular disease among older individuals","volume":"24","author":"Yatsuya","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.115.306883","article-title":"Obesity and cardiovascular disease","volume":"118","author":"Ortega","year":"2016","journal-title":"Circ Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e004080","DOI":"10.1161\/JAHA.116.004080","article-title":"Angina and future cardiovascular events in stable patients with coronary artery disease: insights from the reduction of atherothrombosis for continued health (REACH) registry","volume":"5","author":"Eisen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.112.123117","article-title":"Cardiovascular risk of high-versus moderate-intensity aerobic exercise in coronary heart disease patients","volume":"126","author":"Rognmo","year":"2012","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2017.06.067","article-title":"Effects of high-intensity interval versus continuous exercise training on post-exercise heart rate recovery in coronary heart-disease patients","volume":"244","author":"Villelabeitia-Jaureguizar","year":"2017","journal-title":"Int J Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1111\/bcp.15221","article-title":"Antiplatelet therapy in cardiovascular disease: current status and future directions","volume":"88","author":"Passacquale","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ki.2014.426","article-title":"Incremental prognostic value of kidney function decline over coronary artery disease for cardiovascular event prediction after coronary computed tomography","volume":"88","author":"Bittencourt","year":"2015","journal-title":"Kidney Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","article-title":"Chronic kidney disease and cardiovascular disease: is there any relationship?","volume":"15","author":"Vallianou","year":"2019","journal-title":"Curr Cardiol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3390\/ijms22052298","article-title":"Targeting the renin-angiotensin-aldosterone system to prevent hypertension and kidney disease of developmental origins","volume":"22","author":"Hsu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"104537","DOI":"10.1016\/j.phrs.2019.104537","article-title":"Megalin: a bridge connecting kidney, the renin-angiotensin system, and atherosclerosis","volume":"151","author":"Kukida","year":"2020","journal-title":"Pharmacol Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/s0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"778615","DOI":"10.3389\/fcvm.2021.778615","article-title":"Predictive value of gensini score in the long-term outcomes of patients with coronary artery disease who underwent PCI","volume":"8","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/00132580-200207000-00002","article-title":"The Seattle angina questionnaire: reliability and validity in women with chronic stable angina","volume":"4","author":"Kimble","year":"2002","journal-title":"Heart Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.amjcard.2021.04.029","article-title":"Seattle Angina pectoris questionnaire and Canadian cardiovascular society angina categories in the assessment of total coronary atherosclerotic burden","volume":"152","author":"Guimar\u00e3es","year":"2021","journal-title":"Am J Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/pst.2051","article-title":"To use or not to use propensity score matching?","volume":"20","author":"Wang","year":"2021","journal-title":"Pharm Stat"},{"key":"B33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jchf.2018.09.006","article-title":"Physical activity, fitness, and obesity in heart failure with preserved ejection fraction","volume":"6","author":"Pandey","year":"2018","journal-title":"JACC Heart Fail"},{"key":"B34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1253\/circj.cj-09-0637","article-title":"Coronary score adds prognostic information for patients with acute coronary syndrome","volume":"74","author":"Huang","year":"2010","journal-title":"Circ J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the seattle angina questionnire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1194082\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T03:01:19Z","timestamp":1690513279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1194082\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2023.1194082"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1194082","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"article-number":"1194082"}}